Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Soft Matter|September 7, 2018
Two time scales for self and collective diffusion near the critical point in a simple patchy model for proteins with floating bondsJ Bleibel, M Habiger, M Lütje, et al.
Experimental and Clinical Endocrinology|February 1, 1983
Studies on pharmacokinetics of STS 557 in animal species and manG Hobe, H G Hillesheim, W Schumann, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppressionW Arlt, H G Justl, F Callies, et al.
Journal of Neuroscience Research|May 26, 1999
Radical scavenging compound J 811 inhibits hydrogen peroxide-induced death of cerebellar granule cellsM E Götz, E Ahlbom, B Zhivotovsky, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadismM Schubert, T Minnemann, D Hübler, et al.
Zentralblatt Fur Gynakologie|January 1, 1978
[Postcoital contraception in primates. I. Action mechanism of a potential postovulatory fertility-inhibiting substance STS 456 in the baboon (Papio hamadryas)]N P Goncharov, A Komor, N A Pachalia, et al.
Reproduction, Fertility, and Development|January 22, 2002
Estrogen sulfamates: a new approach to oral estrogen therapyW Elger, A Barth, A Hedden, et al.
Die Pharmazie|August 12, 1998
Evaluation of an oral pulsatile delivery system for melatonin in humansH Hoffmann, M Dittgen, A Hoffmann, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|August 19, 2007
A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoateT Minnemann, M Schubert, D Hübler, et al.
Journal of Endocrinological Investigation|October 15, 2008
Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadismT Minnemann, M Schubert, S Freude, et al.
Pageof 14